The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.
The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).
Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.
Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Ankara, Turchia (Türkiye), 06200
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Receiving hemodialysis treatment for the first time.
- Age ≥18 years.
- No visual, hearing, or cognitive impairment.
- Able to communicate effectively.
- Clinically stable.
- No diagnosed psychiatric disorder or use of psychiatric medication.
- No history of seizures.
- Willing and able to provide informed consent.
Exclusion Criteria:
- Previous hemodialysis treatment.
- Age <18 years.
- Visual, hearing, or cognitive impairment.
- History of kidney transplantation.
- Communication difficulties.
- Diagnosed psychiatric disorder or use of psychiatric medication.
- History of seizures.
- Declined to participate in the study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
|
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes.
The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
|
Comparatore attivo: Control Group
Participants received standard hemodialysis care without any additional intervention.
|
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Systolic Blood Pressure
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in systolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Diastolic Blood Pressure
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in diastolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Heart Rate
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in heart rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Respiratory Rate
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in respiratory rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Body Temperature
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in body temperature measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
State Anxiety Level After Hemodialysis
Lasso di tempo: Immediately after completion of the hemodialysis session.
|
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Pain Score
Lasso di tempo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain.
Higher scores indicate greater pain.
Pain was assessed before and immediately after completion of the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Participant Satisfaction Score
Lasso di tempo: Immediately after completion of the hemodialysis session.
|
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied.
Higher scores indicate greater participant satisfaction.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Direttore dello studio: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- AYBU-2023-208
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .